'Incremental cost effectiveness ratio' presentation slideshows

Pharmacoeconomics 101

Pharmacoeconomics 101. 2005 DoD Pharmacoeconomics & Pharmacy Benefits Conference 11 January LtCol David Bennett, Capt Jill Dacus, Eugene Moore, PharmD. Pharmacoeconomics 101. What is Pharmacoeconomics and how does it apply to formulary management?.

1.75k views • 74 slides

David Cohen Professor of Health Economics Tel: 01443 483827 Email: dcohen@glam.ac.uk

Module 10 Introduction to Health Economics / Pharmacoeconomics. David Cohen Professor of Health Economics Tel: 01443 483827 Email: dcohen@glam.ac.uk. Economics. The study of how people and society end up choosing with or without the use of money to employ scarce resources

599 views • 50 slides

Rochelle Naylor, MD Section of Adult and Pediatric Endocrinology, Diabetes & Metabolism

Cost Effectiveness of Genetic Testing in Monogenic Diabetes. Rochelle Naylor, MD Section of Adult and Pediatric Endocrinology, Diabetes & Metabolism The University of Chicago Medicine. Disclosures. Research funding: American Diabetes Association, Kovler Family Foundation

651 views • 44 slides

Economic evaluation of health programmes

Economic evaluation of health programmes. Department of Epidemiology, Biostatistics and Occupational Health Class no. 17: Economic Evaluation using Decision Analytic Modelling III Nov 5, 2008. Plan of class. Patient-level simulations: an example

532 views • 39 slides

Analysis Alongside A Randomized Trial

Analysis Alongside A Randomized Trial. Todd Wagner, PhD May 2009. Objectives. At the end of the class, you should Understand how to set up your datasets Be familiar with analytical methods Want to hear the class on decision modeling. Dominance.

498 views • 36 slides

The SENIORS trial: effects of beta-blockers in elderly patients with heart failure

The SENIORS trial: effects of beta-blockers in elderly patients with heart failure. Dr Marcus Flather Director Clinical Trials and Evaluation Unit, Royal Brompton Hospital and Imperial College, London Heart Failure 2009, Nice, France. m.flather@rbht.nhs.uk www.cteu.org.

2.41k views • 32 slides

Assessing Value in Cancer Care: Advances in UGI Malignancies as a Case Study

414 views • 30 slides

Role of Pharmacoeconomics in a Developing country context

Role of Pharmacoeconomics in a Developing country context . Gavin Steel for Anban Pillay Cluster Manager: Health Economics National Department of Health Republic of South Africa pillayanban@yahoo.com.au. Range of interventions to improve affordability . Generic substitution policy

480 views • 26 slides

408 views • 26 slides

Introduction

Alternative antiretroviral monitoring strategies for HIV-infected patients in resource-limited settings: Opportunities to save more lives? R Scott Braithwaite, MD, MS, FACP Chief, Section of Value and CER NYU School of Medicine. Introduction.

286 views • 21 slides

Abdulkadir Keskinaslan , MD, MBA, MPH

401 views • 15 slides

Workshop The science and methodologies behind HTA, diversity and commonality across the EU

Workshop The science and methodologies behind HTA, diversity and commonality across the EU. Achieving more patient centred HTA in different countries. Terminology. Patients Citizens Public Service users etc. Rationale for HTA.

265 views • 15 slides